The post 7,798 ETH Moved to Binance After Two-Year Staking, Here’s Who May Stand Behind This appeared on BitcoinEthereumNews.com. According to a recent report publishedThe post 7,798 ETH Moved to Binance After Two-Year Staking, Here’s Who May Stand Behind This appeared on BitcoinEthereumNews.com. According to a recent report published

7,798 ETH Moved to Binance After Two-Year Staking, Here’s Who May Stand Behind This

According to a recent report published by Lookonchain, a large ETH transaction has been made to Binance today. This X account has spotted a massive Ethereum transfer targeting Binance.

It also revealed that the wallet that conducted this transfer may be connected to a large crypto asset managing firm that has been in the market for 10 years already.

7,798 ETH sent to Binance by anonymous whale

Lookonchain shared that the wallet, which has sent a staggering amount of Ethereum (7,798 ETH worth $25 million) to Binance, could be linked to Fenbushi Capital — a major crypto asset management firm founded in 2015.

The analytics account stressed that the 7,798 ETH had been staked for two years and was now withdrawn to be sent to Binance, most likely to be sold.

Notably, this big crypto transfer took place as the second-largest cryptocurrency, Ethereum, experienced a sudden price crash of 4.5% earlier today, crashing from $3,360 to the $3,220 zone, where ETH is changing hands at press time.

A week ago, ETH surged by almost 8%, increasing from $3,080 to the $3,330 level. Between then and today, Ethereum was trading sideways, moving in that price range.

You Might Also Like

Crypto investment products see largest weekly inflow since October

Another large crypto asset manager, CoinShares, has shared a weekly report, sharing stunning news: for the first time since last October, the largest inflow into investment products based on digital assets has taken place.

In particular, the bellwether crypto, Bitcoin, has led the way, with a total of $1.55 billion in investment inflows. Ethereum and Solana received $496 million and $45 million, respectively. XRP has attracted $69.5 million.

Key reason for Bitcoin’s rebound revealed by analyst

As the U.S. has implemented new trade tariffs against Europe, Bitcoin went down, pulling the rest of the crypto market along with it. BTC went down by 3.12%, falling from the $95,460 level to $92,490. By now, it has rebounded to $93,180.

In light of the news, silver has renewed its all-time high, soaring to $94 per ounce. The crypto community seems to be watching this price surge attentively, while Bitcoin has been unable to hit a new historic price peak yet. Still, a CryptoQuant analyst believes that behind the BTC rebound stands “the recovery of real buying demand in the spot market.”

Source: https://u.today/7798-eth-moved-to-binance-after-two-year-staking-heres-who-may-stand-behind-this

Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$2,926.22
$2,926.22$2,926.22
-0.53%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26